Naomi Birbach is a partner in Goodwin’s IP Litigation group and focuses her practice on patent matters across a wide variety of industries, including pharmaceuticals, electronic devices, display systems, and software. Naomi has represented clients in numerous patent infringement lawsuits in federal courts nationwide and has significant trial experience. She also represents clients before the Patent Trial and Appeal Board (PTAB) in post-grant proceedings such as inter partes reviews (IPRs).
Naomi has experience representing companies in all stages of patent litigation, from pre-suit investigation through trial and appeal. Matter highlights include:
Representative Technology Experience:
Representative Pharmaceuticals Experience:
Naomi is member of the New York Intellectual Property Law Association (NYIPLA).
Prior to entering law school, Naomi was a patent examiner at the U.S. Patent and Trademark Office.
Naomi has been selected for inclusion in The Legal 500 U.S. 2022.
Naomi has been recognized by The Best Lawyers in America Ones to Watch for her work in Litigation - Patent 2022.
Naomi was named to The Best Lawyers in America 2021: Ones to Watch.
Naomi is the Senior Project Editor of the firm’s biosimilars blog, Big Molecule Watch, which provides resources and observations through Goodwin’s active watch of legal, business and regulatory developments related to biologics, biosimilars, and the Biologics Price Competition and Innovation Act (BPCIA). Naomi was also a contributor to Goodwin’s, Guide to Biosimilars Litigation and Regulation in the U.S., 2019-2020 ed., published by Thomson Reuters. Naomi was also a Special Contributor to, Guide to Biosimilars Litigation and Regulation in the U.S., 2021-2022 ed., published by Thomson Reuters, October 2022. Additionally, Naomi was a Contributor to, Guide to Biosimilars Litigation and Regulation in the U.S., 2022-2023 ed., published by Thomson Reuters, December 2022. Naomi recently co-authored an article titled “3 Reasons Beauty Cos. Should Consider Pursuing Patents,” which was featured in the expert analysis section of the website Law360.
(cum laude)
客户信赖我们世界一流的咨询服务，希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题，涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息，请与我们联系。
Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.
Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.